![Luca Benatti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luca Benatti
Chief Executive Officer at
TES Pharma SRL
Net worth: 6 458 $ as of 31/10/2026
Profile
Luca Benatti was the founder of Newron Pharmaceuticals SpA, founded in 1998, and served as Independent Non-Executive Director from 2012 to 2026.
Current jobs include Chief Executive Officer & Director at TES Pharma SRL since 2024, Chairman at Italian Angels For Biotech, Independent Director at Metis Precision Medicine Sb Srl, Director at CaSRevolution Srl, and Principal at The European Association for Bioindustries.
Former jobs include Chief Executive Officer & Director at Quince Therapeutics SpA from 2012 to 2023, Vice Chairman at Assobiotec, Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2023, Independent Director at Quince Therapeutics, Inc. from 2023 to 2026, and Head-Molecular Neurobiology Department at Pharmacia & Upjohn SpA in 1998.
Education includes undergraduate studies at the University of Milan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 26/12/2025 | 196 ( 0% ) | 6 458 $ | 31/10/2026 |
Luca Benatti active positions
| Companies | Position | Start |
|---|---|---|
TES Pharma SRL
 TES Pharma SRL Medical SpecialtiesHealth Technology Provides vitro diagnostics | Chief Executive Officer | 01/02/2024 |
Italian Angels For Biotech
 Italian Angels For Biotech Investment ManagersFinance IAB invests in companies located in Italy. The firm target companies operating in the field of life sciences. It provides financing for early stage capital requirements with investment size ranging from EUR 0.005 - 0.1 million. It also takes board seat and acts as lead investor. | Chairman | - |
Metis Precision Medicine Sb Srl
 Metis Precision Medicine Sb Srl Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies | Director/Board Member | - |
CaSRevolution SRL
 CaSRevolution SRL Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company that develops therapies for neurodegenerative diseases | Director/Board Member | - |
The European Association for Bioindustries | Corporate Officer/Principal | 30/04/2010 |
Former positions of Luca Benatti
| Companies | Position | End |
|---|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Chief Executive Officer | 15/05/2012 |
| IRULYA THERAPEUTICS INC. | Director/Board Member | 30/01/2026 |
| INTERCEPT PHARMACEUTICALS, INC. | Director/Board Member | 08/11/2023 |
EryDel SpA
 EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Chief Executive Officer | 01/09/2023 |
| ░░░░░░░░░ ░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Education of Luca Benatti
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Newron Pharmaceuticals SpA
 Newron Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and sells novel therapies central & peripheral nervous system | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EryDel SpA
EryDel SpA BiotechnologyHealth Technology Operates as a biotech company that develops therapeutics for the treatment of rare diseases | Health Technology |
The European Association for Bioindustries | |
Assobiotec
 Assobiotec Miscellaneous Commercial ServicesCommercial Services Operates as professional association for the development of biotechnology | Commercial Services |
Pharmacia & Upjohn SpA | |
TES Pharma SRL
TES Pharma SRL Medical SpecialtiesHealth Technology Provides vitro diagnostics | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Italian Angels For Biotech
Italian Angels For Biotech Investment ManagersFinance IAB invests in companies located in Italy. The firm target companies operating in the field of life sciences. It provides financing for early stage capital requirements with investment size ranging from EUR 0.005 - 0.1 million. It also takes board seat and acts as lead investor. | Finance |
Metis Precision Medicine Sb Srl
Metis Precision Medicine Sb Srl Miscellaneous Commercial ServicesCommercial Services Develops cancer therapies | Commercial Services |
CaSRevolution SRL
CaSRevolution SRL Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company that develops therapies for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Luca Benatti
